Stocktoria
Teladoc Health, Inc. TDOC
Teladoc Health, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.6B | $2.6B | $2.4B | $2.0B | $1.1B | $553.3M | $417.9M | $233.3M | $123.2M |
| Gross profit | — | — | — | — | — | — | — | $289.2M | $171.7M | $91.2M |
| R&D expense | $277.9M | $307.3M | $348.5M | $333.6M | $311.9M | $164.9M | $64.6M | $54.4M | $34.5M | $21.8M |
| Operating income | -$263.0M | -$1.0B | -$248.6M | -$13.7B | -$265.6M | -$506.4M | -$80.4M | -$70.9M | -$75.4M | -$62.7M |
| Interest expense | — | $23.8M | $22.3M | $21.9M | $81.1M | — | — | — | — | — |
| Income tax | -$35.2M | $7.6M | $760,000 | -$3.8M | $44.1M | -$90.9M | -$10.6M | $118,000 | -$225,000 | $510,000 |
| Net income | -$200.3M | -$1.0B | -$220.4M | -$13.7B | -$428.8M | -$485.1M | -$98.9M | -$97.1M | -$106.8M | -$74.2M |
| EPS (diluted) | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 | $-5.36 | $-1.38 | — | — | — |
| Operating cash flow | $294.4M | $293.7M | $350.0M | $189.3M | $194.0M | -$53.5M | $29.9M | -$4.9M | -$34.4M | -$51.9M |
| Free cash flow | $285.5M | $282.9M | $338.6M | $172.8M | $185.5M | -$57.5M | $26.4M | -$8.9M | -$37.1M | -$54.0M |
| Cash & equivalents | $781.1M | $1.3B | $1.1B | $918.2M | $893.5M | $733.3M | $514.4M | $424.0M | $42.8M | $50.0M |
| Inventory | $38.2M | $38.1M | $29.5M | $56.3M | $73.1M | $56.5M | $0 | — | — | — |
| Total assets | $2.9B | $3.5B | $4.4B | $4.3B | $17.7B | $17.8B | $1.6B | $1.5B | $824.4M | $303.7M |
| Total liabilities | $1.5B | $2.0B | $2.1B | — | — | — | — | — | — | — |
| Shareholders' equity | $1.4B | $1.5B | $2.3B | $2.3B | $16.0B | $15.9B | $1.0B | $1.0B | $558.9M | $230.9M |
Growth · year-over-year · Revenue CAGR 39.9%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -1.5% | -1.3% | +8.1% | +18.4% | +85.8% | +97.7% | +32.4% | +79.1% | +89.4% | +59.2% |
| Free cash flow growth | +0.9% | -16.4% | +95.9% | -6.8% | — | -318.3% | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.